Australian Healthcare Strong Balance Sheet Stocks

Anteris Technologies Global

Market Cap: AU$239.8m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Rhythm Biosciences

Market Cap: AU$26.8m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

Micro-X

Market Cap: AU$54.1m

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Healius

Market Cap: AU$544.6m

Provides medical laboratory and pathology services in Australia.

Cyclopharm

Market Cap: AU$87.8m

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.

Pacific Smiles Group

Market Cap: AU$246.5m

Owns and operates dental centers under the Pacific Smiles Dental and Nib Dental Care Centres names in Australia.

TrivarX

Market Cap: AU$6.2m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

Australian Clinical Labs

Market Cap: AU$466.7m

Provides pathology diagnostic services in Australia.

Virtus Health

Market Cap: AU$705.2m

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore.

Clever Culture Systems

Market Cap: AU$67.6m

Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, China, Netherlands, and Germany.

Neurotech International

Market Cap: AU$17.8m

A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

Lumos Diagnostics Holdings

Market Cap: AU$113.9m

Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States.

Nova Eye Medical

Market Cap: AU$47.0m

Designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally.

INOVIQ

Market Cap: AU$44.7m

Develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

Imricor Medical Systems

Market Cap: AU$450.7m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Beamtree Holdings

Market Cap: AU$66.8m

Provides artificial intelligence-based decision support software and data insight solutions, and other software services to the healthcare industry in Australia and internationally.